On the cutting edge – Carbon nanotube cutlery

Researchers at NIST and the University of Colorado at Boulder have designed a prototype carbon nanotube “knife” that would work like a tight-wire cheese slicer for cutting cells, allowing scientists to study them more precisely than they can today.

Anemia :: Mircera – first drug to correct anaemia in all chronic kidney disease patients

Results from two Roche studies show for the first time that chronic kidney disease patients on dialysis as well as those not on dialysis who need correction of renal anaemia, can be successfully treated with Mircera on a simple twice monthly dosing schedule ? an option that does not exist today. Mircera was shown to be as effective as existing agents in correcting renal anaemia while reducing the dosing frequency 2 to 6-fold of these drugs. Two phase III trials demonstrating these findings were presented at the 39th annual meeting of the American Society of Nephrology in San Diego, USA.

ADHD :: Shire bioequivalence study results of SPD465, investigational drug for adults with ADHD

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults for up to 16 hours, was bioequivalent to a dose of ADDERALL XR (mixed salts of a single-entity amphetamine product) followed by a dose of mixed amphetamine salts immediate release (“MAS IR”) eight hours later.

Rheumatoid Arthritis :: Repeat treatment with MabThera provides continuous improvement of quality of life in RA patients

Data presented at this year’s American College of Rheumatology Congress (ACR) show that patients receiving repeat treatment with MabThera/Rituxan (rituximab) achieved continued improvement in both physical and mental aspects of quality of life measures. In addition, a higher proportion of patients achieved a significant improvement in disease symptoms with a second course of MabThera, compared to the first course they received.

Health :: Antioxidants – New kid on the block for pain relief?

Antioxidant-based pain killers may one day become a viable alternative to addictive medications such as morphine. Researchers found that synthetic antioxidants practically eradicated pain-like behavior in nearly three-quarters of mice with inflamed hind paws.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack